Macrocyclic inhibitors of hepatitis C virus

Compounds of the formula (I), and N-oxides, salts, and stereoisomers thereof wherein A is OR, NHS(=O)R; wherein; R is hydrogen, C-Calkyl, C-Calkylenecarbocyclyl, C-Calkylene-heterocyclyl; R is C-Calkyl, C-Calkylenecarbocyclyl, C-Calkyleneheterocyclyl; p is independently 1 or 2; n is 3, 4, 5 or 6; --...

Full description

Saved in:
Bibliographic Details
Main Authors WAHLING, HORST JURGEN, RABOISSON, PIERRE JEAN-MARIE BERNARD, DE KOCK, HERMAN AUGUSTINUS, KAHNBERG, PIA CECILIA, SAHLBERG, SVEN CRISTER, BELFRAGE, ANNA KARIN GERTRUD LINNEA, ROSENQUIST, ASA ANNICA KRISTINA, WALLBERG, HANS KRISTIAN, SAMUELSSON, BENGT BERTIL, CLASSON, BJORN OLOF, HU, LILI, LINDQUIST, KARIN CHARLOTTA, LINDSTROM, MATS STEFAN, NILSSON, KARL MAGNUS, SIMMEN, KENNETH ALAN
Format Patent
LanguageEnglish
Published 12.04.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the formula (I), and N-oxides, salts, and stereoisomers thereof wherein A is OR, NHS(=O)R; wherein; R is hydrogen, C-Calkyl, C-Calkylenecarbocyclyl, C-Calkylene-heterocyclyl; R is C-Calkyl, C-Calkylenecarbocyclyl, C-Calkyleneheterocyclyl; p is independently 1 or 2; n is 3, 4, 5 or 6; --- deonotes an optional double bond; L is N or CRz; Rz is H or forms a double bond with the asterisked carbon; Rq is H or when L is CRz, Rq can also be C-Calkyl; Rr is quinazolinyl, optionally substituted with one two or three substituents each independently selected from C-C alkyl, C-Calkoxy, hydroxyl, halo, haloC-Calkyl, amino, mono- or dialkylamino, mono- or dialkylaminocarbonyl, C-Calkyl- carbonylamino, C-Calkylenecarbocyclyl and C-C alkyleneheterocyclyl; R is hydrogen, C-Calkyl, C-CalkoxyC-Calkyl or C-Ccycloalkyl; R is hydrogen, C-Calkyl, C-Calkoxy, C-Calkylenecarbocyclyl, C-Calkyleneheterocyclyl, hydroxy, bromo, chloro or fluoro have utility in the treatment or prophylaxis of flaviviral infections such as HCV.
Bibliography:Application Number: AU20060274866